Artificial Intelligence used to design new viruses

bbc.co.uk
August 7, 2026
4 min read
44/100
Summary
Artificial Intelligence has been successfully used to design 16 novel viruses that can replicate in laboratory conditions and infect bacteria. This marks the first instance of AI designing whole genomes, representing a significant advancement in scientific research.
Key Takeaways
- AI has been used to design fully functional viruses that can replicate in the laboratory, marking the first successful creation of whole genomes by AI.
- Sixteen novel bacteriophages were developed to specifically target and kill E. coli bacteria, demonstrating potential for new infection treatments.
- The research raises urgent biosafety and biosecurity concerns regarding the potential misuse of AI-designed viruses to create harmful pathogens.
- The AI models used for this research, Evo1 and Evo2, were trained on genetic codes from various organisms and represent a significant advancement in synthetic biology.
Coverage & discussions
Hacker News Ā· bbc.co.uk
Community discussions
Historical count: 5 Ā· 5 saved in sample Ā· Historical sample
Analysis ready
Community Sentiment
Positives
- The study's approach to using AI for designing phages shows potential for innovative treatments against bacterial infections, which could be groundbreaking in the medical field.
Concerns
- Generative models for DNA sequences could lead to dangerous technologies, raising fears about the possible creation of lethal viruses that evade immune responses.
- Publicly releasing model weights poses a risk of irreversible proliferation, making the development of bioweapons a real concern that can't be dismissed as far-fetched.
- Commenters worry that the AI-generated designs might be overhyped, lacking sufficient context about their success rates and prior research.
Related Articles

AI Can Now Design Functional Viruses. Should We Worry?
Aug 15, 2026

Alternatives to Animal Testing Are Finally Taking Off
Oct 19, 2026

The Sloppification of Peptides
Aug 23, 2026

Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
Aug 19, 2026

Transformer Transformer: A Unified Model for Motion-Conditioned Robot Co-Design
Jul 29, 2026